Alerts will be sent to your verified email
Verify Email
BROOKS
|
Brooks Laboratories
|
Medico Remedies
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-23.88 % | 13.93 % | 6.92 % |
|
5yr average Equity Multiplier
|
1.78 | 2.07 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 1.49 | 0.55 |
|
5yr Avg Net Profit Margin
|
-23.79 % | 4.73 % | 8.69 % |
|
Price to Book
|
3.95 | 6.42 | 1.92 |
|
P/E
|
0.0 | 38.86 | 43.02 |
|
5yr Avg Cash Conversion Cycle
|
-10.34 Days | 53.33 Days | 49.75 Days |
|
Inventory Days
|
93.5 Days | 48.95 Days | 84.58 Days |
|
Days Receivable
|
66.75 Days | 129.15 Days | 139.4 Days |
|
Days Payable
|
179.8 Days | 124.28 Days | 264.75 Days |
|
5yr Average Interest Coverage Ratio
|
-11.84 | 11.55 | 7.03 |
|
5yr Avg ROCE
|
-15.03 % | 20.03 % | 10.34 % |
|
5yr Avg Operating Profit Margin
|
-13.23 % | 7.11 % | 15.51 % |
|
5 yr average Debt to Equity
|
0.21 | 0.26 | 0.15 |
|
5yr CAGR Net Profit
|
0.22 % | 31.26 % | -11.57 % |
|
5yr Average Return on Assets
|
-14.62 % | 6.88 % | 4.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 62.59 % | 40.46 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | -10.75 % | -3.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | 0.0 | 0.0 |
|
Brooks Laboratories
|
Medico Remedies
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|